Literature DB >> 20809160

[Cementless humeral head replacement for dislocation arthropathy of the shoulder joint].

B S Werner1, F Gohlke.   

Abstract

BACKGROUND: Only a few reports in the literature describe that total shoulder replacement provides better functional results in dislocation arthropathy than hemiarthroplasty. Nevertheless, the risk of aseptic loosening in young and active patients is high after long-term follow-up. We evaluated the results of cementless humeral head resurfacing in this group.
METHODS: We evaluated 29 patients with dislocation arthropathy who had been followed up for a mean of 39 months. The mean age at the time of operation was 43.7±14.7 years. Preoperatively, cuff deficiency was seen in 11 cases.
RESULTS: The mean adjusted Constant score improved from 16.8±15.2% to 78.1±21.9%. Negative prognostic factors turned out to be female sex, age, cuff tears especially of the subscapularis tendon, and previous bone block procedures. Revision was performed in five patients, and two developed painful glenoid erosion which required conversion to total shoulder arthroplasty.
CONCLUSION: Cementless humeral head replacement is a viable option in the treatment of dislocation arthropathy. Revision can be performed easily since the bone stock has been preserved. On the basis of our data, humeral head replacement in patients <40 years with dislocation arthropathy offers promising short- to midterm results with an acceptable complication rate.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809160     DOI: 10.1007/s00132-010-1655-8

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  16 in total

1.  Shoulder arthroplasty for advanced glenohumeral arthritis after anterior instability repair.

Authors:  A Green; T R Norris
Journal:  J Shoulder Elbow Surg       Date:  2001 Nov-Dec       Impact factor: 3.019

2.  Glenohumeral osteoarthrosis. A late complication of the Putti-Platt repair.

Authors:  R J Hawkins; R L Angelo
Journal:  J Bone Joint Surg Am       Date:  1990-09       Impact factor: 5.284

3.  Shoulder arthroplasty for arthritis after instability surgery.

Authors:  John W Sperling; Samuel A Antuna; Joaquin Sanchez-Sotelo; Cathy Schleck; Robert H Cofield
Journal:  J Bone Joint Surg Am       Date:  2002-10       Impact factor: 5.284

4.  [Bankart procedure: clinical and radiological long-term outcome].

Authors:  D Chapnikoff; A Besson; C Chantelot; C Fontaine; H Migaud; A Duquennoy
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  2000-10

5.  Long-term followup of Bankart reconstruction. Incidence of late degenerative glenohumeral arthrosis.

Authors:  B N Rosenberg; J C Richmond; W N Levine
Journal:  Am J Sports Med       Date:  1995 Sep-Oct       Impact factor: 6.202

6.  Cementless humeral resurfacing arthroplasty in active patients less than fifty-five years of age.

Authors:  David S Bailie; Paulo J Llinas; Todd S Ellenbecker
Journal:  J Bone Joint Surg Am       Date:  2008-01       Impact factor: 5.284

7.  Long-term results of the Latarjet procedure for the treatment of anterior instability of the shoulder.

Authors:  J Allain; D Goutallier; C Glorion
Journal:  J Bone Joint Surg Am       Date:  1998-06       Impact factor: 5.284

8.  Glenohumeral arthroplasty for arthritis after instability surgery.

Authors:  L U Bigliani; D M Weinstein; M T Glasgow; R G Pollock; E L Flatow
Journal:  J Shoulder Elbow Surg       Date:  1995 Mar-Apr       Impact factor: 3.019

9.  Dislocation arthropathy of the shoulder.

Authors:  R L Samilson; V Prieto
Journal:  J Bone Joint Surg Am       Date:  1983-04       Impact factor: 5.284

10.  [Shoulder arthroplasty for osteoarthritis after prior surgery for anterior instability: a report of 27 cases].

Authors:  J Matsoukis; W Tabib; P Guiffault; G Walch
Journal:  Rev Chir Orthop Reparatrice Appar Mot       Date:  2003-11
View more
  1 in total

1.  [Resurfacing of the humeral head : sensible indications].

Authors:  B Fink; A Niemeier; W Rüther
Journal:  Orthopade       Date:  2013-07       Impact factor: 1.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.